This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Oct;34(9):698-701.

doi: 10.1007/BF03345405.

Hypoglycemia and insulin treatment

F Febo¹, C Molinari, P M Piatti

Affiliations

PMID: 22156904
DOI: 10.1007/BF03345405

Hypoglycemia and insulin treatment

F Febo et al. J Endocrinol Invest. 2011 Oct.

. 2011 Oct;34(9):698-701.

doi: 10.1007/BF03345405.

Authors

F Febo¹, C Molinari, P M Piatti

Affiliation

¹ San Raffaele Scientific Institute, Department of Internal Medicine, Milan, Italy.

PMID: 22156904
DOI: 10.1007/BF03345405

No abstract available

PubMed Disclaimer

Similar articles

Long-acting insulin analogs versus human insulins.
Garg SK, Naik RG. Garg SK, et al. Diabetes Technol Ther. 2008 Oct;10(5):331-2. doi: 10.1089/dia.2008.0071. Diabetes Technol Ther. 2008. PMID: 18715208 No abstract available.
Newer basal insulin analogues: degludec, detemir, glargine.
Kalra S. Kalra S. J Pak Med Assoc. 2013 Nov;63(11):1442-4. J Pak Med Assoc. 2013. PMID: 24392539 Review. No abstract available.
Are long-acting insulin analogues better than isophane insulin?
Schooff MD, Gupta L. Schooff MD, et al. Am Fam Physician. 2008 Feb 15;77(4):447-9. Am Fam Physician. 2008. PMID: 18326162 Review. No abstract available.
Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?
Valensi P, Cosson E. Valensi P, et al. Diabetes Metab. 2005 Sep;31(4 Pt 2):4S34-4S39. doi: 10.1016/s1262-3636(05)88265-5. Diabetes Metab. 2005. PMID: 16389896 Review.
Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.
White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group. White NH, et al. Diabetes Care. 2009 Mar;32(3):387-93. doi: 10.2337/dc08-0800. Epub 2008 Dec 23. Diabetes Care. 2009. PMID: 19106380 Free PMC article. Clinical Trial.

See all similar articles

Cited by

Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.
Cruz B, Flores RJ, Uribe KP, Espinoza EJ, Spencer CT, Serafine KM, Nazarian A, O'Dell LE. Cruz B, et al. Neuropsychopharmacology. 2019 May;44(6):1141-1151. doi: 10.1038/s41386-018-0306-3. Epub 2019 Jan 7. Neuropsychopharmacology. 2019. PMID: 30647447 Free PMC article.
Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes.
Íbias J, O'Dell LE, Nazarian A. Íbias J, et al. Behav Brain Res. 2018 Oct 1;351:75-82. doi: 10.1016/j.bbr.2018.05.018. Epub 2018 May 24. Behav Brain Res. 2018. PMID: 29803655 Free PMC article.

References

1. Lancet. 2000 Aug 5;356(9228):443-5 - PubMed
1. J Am Geriatr Soc. 2007 Nov;55(11):1735-40 - PubMed
1. Diabetes Care. 2011 May;34(5):1164-70 - PubMed
1. Diabetes. 2004 Jun;53(6):1614-20 - PubMed
1. Diabetes Care. 2006 Jun;29(6):1269-74 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information